Feb 03, 2022 / 11:00AM GMT
Christopher David O'Reilly - Takeda Pharmaceutical Company Limited - Global Head of IR & Global Finance
[Interpreted] Thank you very much for joining our Fiscal Year 2021 Third Quarter Earnings Announcement. I am the moderator. I'm Chris O'Reilly, Head of the Global IR. And we have the interpretation button at the bottom of the Zoom. And if you'd like to listen to Japanese, please select the Japanese language. And if you like to listen to English, please select the English channel. And if you'd like to listen to the original audio, please turn the interpretation function off.
Before starting, I'd like to remind everyone that we will be discussing forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those discussed today. The factors that could cause our actual results to differ materially are discussed in our most recent Form 20-F and in our other SEC filings. Please also refer to the important notice on Page 2 of the presentation material for today.
Today, our presenters as
Q3 2022 Takeda Pharmaceutical Co Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot